A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Ki vehet részt

• Participants with the ability to understand the requirements of the trial, provide written informed consent, and comply with the trial protocol procedures
• Male or female participants aged ≥ 18 years
• Participants with diagnosis of GD who are hyperthyroid despite ATD treatment
• Other, more specific inclusion criteria are defined in the protocol

Ki nem vehet részt

• Have previously been successfully treated with radioactive iodine (RAI) therapy or have undergone total thyroidectomy
• Have an autoimmune disease other than GD requiring treatment that, in the Investigator's judgment, puts the participant at undue risk
• Have moderate-to-severe active thyroid eye disease (TED) and are expected to require immediate surgical intervention and/or are planning corrective surgery/irradiation or medical therapy for TED during study participation
• Additional exclusion criteria are defined in the protocol